FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 19, 2005--Andrx
Corporation (Nasdaq:ADRX) is scheduled to present on Monday, May 23,
2005, at 3:30 PM ET at the UBS Global Pharmaceuticals Conference at
the Grand Hyatt Hotel in New York City. Angelo C. Malahias, Andrx
Corporation's President, will present on behalf of the Company.
The presentation will be webcast live on the Internet at the
following web address:
http://event.streamx.us/event/default.asp?event=ubs20050523
A replay of the presentation will be available three hours
following the broadcast and will be available until June 23, 2005. It
may be accessed through the same web address. A link to the broadcast,
along with the slides for this presentation, will be available on
Andrx's website at: http://www.andrx.com.
About Andrx Corporation:
We are a pharmaceutical company that:
- develops, manufactures and commercializes generic versions of
controlled-release, niche and immediate-release pharmaceutical
products, including oral contraceptives;
- distributes pharmaceuticals, primarily generics, which have
been commercialized by others, as well as our own, primarily
to independent pharmacies, pharmacy chains, pharmacy buying
groups and physicians' offices; and
- develops and manufactures pharmaceutical products for other
pharmaceutical companies, including combination products and
controlled-release formulations utilizing our patented
technologies and formulation capabilities.
This release and additional information about Andrx Corporation
are also available on the Internet at: http://www.andrx.com.
CONTACT: Andrx Corporation, Fort Lauderdale
Allison Tomek, 954-382-7696
Email: allison.tomek@andrx.com
SOURCE: Andrx Corporation
